72886-42-1

Basic information

• Product Name: Methyl 3-Mercaptobenzoate
• Synonyms: 3-Mercapto-benzoic Acid Methyl Ester
• CAS NO: 72886-42-1
• Molecular Formula: C₈H₈O₂S
• Molecular Weight: 168.22
• Product Categories: Metal Isotopes;Sulfur & Selenium Compounds
• Mol File: 72886-42-1.mol

Chemical Properties

• Boiling Point: 65-75°C/0.5 mm
• Flash Point: 167.5°C
• Appearance: /
• Density: 1.202g/cm³
• Vapor Pressure: 0.00866mmHg at 25°C
• Refractive Index: 1.574
• Storage Temp.: Refrigerator, Under Inert Atmosphere
• Solubility: Chloroform (Slightly), DMSO (Slightly), Ethyl Acetate (Slightly), Methanol (Slig
• PKA: 5.89±0.10(Predicted)
• Stability: Sensitive to Oxidation
• CAS DataBase Reference: Methyl 3-Mercaptobenzoate(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl 3-Mercaptobenzoate(72886-42-1)
• EPA Substance Registry System: Methyl 3-Mercaptobenzoate(72886-42-1)

Safety Data

• Hazardous Substances Data: 72886-42-1(Hazardous Substances Data)

Usage

Chemical Properties

Clear Colourless Oil

Uses

Methyl 3-Mercaptobenzoate, ~85% (cas# 72886-42-1) is a compound useful in organic synthesis.

InChI:InChI=1/C8H8O2S/c1-10-8(9)6-3-2-4-7(11)5-6/h2-5,11H,1H3

Upstream product

• 4025-64-3 3-Carboxybenzenesulfonyl chloride 
• 99-05-8 meta-aminobenzoic acid 
• 67-56-1 methanol 
• 4869-59-4 3-mercapto benzoic acid 

Downstream Products

• 88489-62-7 3-(1,1,2,2-tetrafluoro-1-trifluoromeytylethylthio)benzoicacid methyl ester 
• 137915-51-6 1-<<2-(tert-butyldimethylsiloxy)ethoxy>methyl>-6-<<3-(methoxycarbonyl)phenyl>thio>thymine 
• 119327-76-3 methyl 6-(3-cyanophenyl)-6-(3-(methoxycarbonyl)phenylthio)-3-methylhexanoate 
• 145970-44-1 3-{7-[1-(tert-Butyl-dimethyl-silanyloxy)-nonyl]-naphthalen-2-ylmethylsulfanyl}-benzoic acid methyl ester 
• 145300-70-5 3-{7-[1-(tert-Butyl-dimethyl-silanyloxy)-nonyl]-quinolin-2-ylmethylsulfanyl}-benzoic acid methyl ester 
• 141311-23-1 (E)-3-<<<5-(dodecyloxy)-6-<2-(methoxycarbonyl)vinyl>pyridin-2-yl>methyl>sulfanyl>benzoic acid methyl ester 
• 368884-36-0 methyl 3-{[(2-{[(1S)-2-(1H-imidazol-1-yl)-1-phenylethyl]oxy}-5-oxo-5,6,7,8-tetrahydro-1-naphthalenyl)methyl]sulfonyl}benzoate 
• 1227843-18-6 3-(5-chloro-pyridin-2-ylsulfanyl)-benzoic acid methyl ester 
• 88489-59-2 methyl 3-[(trifluoromethyl)sulfanyl]benzoate 
• 293758-78-8 4-(tert-butyl-dimethyl-silanoxy)-3-(3-methoxycarbonyl-phenylsulfanylmethyl)-indazole-1-carboxylic acid tert-butyl ester 
• 88489-61-6 3-Heptafluoropropylsulfanyl-benzoic acid methyl ester 
• 125197-81-1 3-((Z)-3-Oxo-propenylsulfanyl)-benzoic acid methyl ester 
• 125197-81-1 methyl (1E)-3-(3-oxo-1-propenylthio)benzoate 
• 907997-34-6 3-mercapto-benzoic acid hydrazide 

Relevant articles and documents

ALPHA-D-GALACTOSIDE INHIBITORS OF GALECTINS

The present invention relates to a compound of the general formula (1). wherein the pyranose ring is a-D-galactopyranose, A is selected from The compound of formula (1) is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human. Furthermore the present invention concerns compounds for use in a method of treatment of a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human.

Ruthenium-Catalyzed Hydroarylation and One-Pot Twofold Unsymmetrical C?H Functionalization of Arenes

A methyl phenyl sulfoximine (MPS) is used as a directing group in the ruthenium-catalyzed intramolecular hydroarylation of alkene-tethered benzoic acid derivatives to afford dihydrobenzofurans and indolines in good to excellent yields. A one-pot, unsymmetrical, twofold C?H functionalization involving intramolecular C?C and intermolecular C?C/C?N bond formations is successfully demonstrated by using a single set of catalytic reaction conditions, which is unprecedented thus far. A novel isoquinolone-bearing dihydrobenzofuran is constructed through an unsymmetrical twofold C?H functionalization.

BICYCLIC COMPOUND

Provided is a pharmaceutical agent containing a compound represented by General Formula (1), a pharmaceutically acceptable salt thereof, or a solvate thereof: wherein A represents a C1-C3 linear alkylene group, in which one methylene group is optionally substituted with O or S; n represents an integer of from 3 to 5; X1 and X2 each independently represent CH or N; W1 and W2 each independently represent a carboxyl group or a tetrazolyl group; V represents a C1-C8 linear or branched alkylene group, in which one methylene group is optionally substituted with O or S; and R represents a substituted phenyl group, for example.

NOVEL ACRIDINE DERIVATIVES

The present invention relates to novel acridine derivatives of formula (I), or pharmaceutically acceptable salts thereof, which are inhibitors of the telomerase enzyme function. These compounds are useful for the treatment cellular proliferation disorders

DERIVATIVES OF 4-(2-AMINO-1-HYDROXIETHYL)PHENOL AS AGONISTS OF THE β2 ADRENERGIC RECEPTOR

This invention is directed to compounds of formula (I): to pharmaceutical compositions comprising them; to combination products comprising them; and to their use in therapy.

HISTONE DEACETYLASE INHIBITORS

The present invention provides histone deacetylase inhibitors of general formula (I), process for the preparation of such compounds and uses of the compounds in medicine.

Novel inhibitors of DNA gyrase: 3D structure based biased needle screening, hit validation by biophysical methods, and 3D guided optimization. A promising alternative to random screening

Random screening provided no suitable lead structures in a search for novel inhibitors of the bacterial enzyme DNA gyrase. Therefore, an alternative approach had to be developed. Relying on the detailed 3D structural information of the targeted ATP bindin

Diarylstrylquinoline diacids and pharmaceutical compositions thereof

Compounds having the formula: STR1 are leukotriene antagonists and inhibitors of leukotriene biosynthesis. These compounds are useful as anti-asthmatic, anti-allergic, anti-inflammatory, and cytoprotective agents.